Please login to the form below
HGS Europe
This page shows the latest HGS Europe news and features for those working in and with pharma, biotech and healthcare.
IMS Health pays €385m for Cegedim businesses
The decision to acquire the Cegedim businesses follows IMS Health's acquisition of HGS Europe at the end of last year, a move that allowed it to expand its market access
Latest news
-
IMS Health acquires HGS Europe
IMS Health UK has acquired HGS Europe in a move that expands its market access capabilities in the UK and Ireland. ... The deal sees HGS Europe's founders Graeme and Angela McFarlane (pictured right) bring the market access services of HGS to the IMS
-
The PM Society Advertising Awards 2008
By: Junction 11. For: Ipsen UK. (L-R) John Flaherty, GSW Europe; Angela McFarlane, HGS Consultancy (sponsor) and Richard Rayment, GSW Junction 11. ... L-R) Joanna Chin, Langland (sponsor); Judith Wilson, GSW Junction 11; John Flaherty, GSW Europe;
More from news
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Pillars of success in market access
The Author. Angela McFarlane is Managing Director, HGS Europe Limited.
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Amgen gets block on sales of Repatha rival in Germany
- Congress is in session – how companies are boosting their impact and engagement
- The state of pharma customer experience
PMHub
Anthem PR
With a rare strength in media and influencer relations, Anthem’s award-winning team offers a fresh approach to health PR...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
